Sotera Health Company (SHC)

NASDAQ: SHC · Real-Time Price · USD

17.53

-0.23 (-1.30%)

At close: Jul 29, 2026, 4:00 PM EDT

17.53

0.00 (0.00%)

After-hours: Jul 29, 2026, 4:55 PM EDT

Sotera Health Company Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,999	5,016	3,878	4,766	2,353	6,664
Market Cap Growth	43.18%	29.36%	-18.63%	102.57%	-64.70%	-14.26%
Enterprise Value	6,944	6,944	5,950	6,791	3,988	8,385
Last Close Price	17.53	17.64	13.68	16.85	8.33	23.55

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	42.92	65.33	85.50	93.61	-	57.44
Forward PE	17.82	19.12	18.03	18.81	8.38	24.18
PEG Ratio	-	1.37	1.50	0.79	0.47	1.34
PS Ratio	4.19	4.31	3.52	4.54	2.34	7.15
PB Ratio	8.14	8.28	9.58	10.74	6.72	11.37
P/FCF Ratio	51.50	33.63	85.99	-	24.61	37.15
P/OCF Ratio	19.10	17.47	17.30	-	8.46	23.67

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.84	5.97	5.41	6.47	3.97	9.00
EV/EBITDA Ratio	13.68	13.92	12.90	15.63	10.13	20.57
EV/EBIT Ratio	18.23	19.18	19.99	24.54	16.06	32.66
EV/FCF Ratio	71.70	46.55	131.94	-	41.73	46.75

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	3.61	3.71	5.75	5.20	5.21	3.10
Debt / EBITDA Ratio	4.47	4.56	5.10	5.35	5.16	4.48
Debt / FCF Ratio	23.44	15.24	52.13	-	21.26	10.19
Net Debt / Equity Ratio	3.14	3.18	5.12	4.56	4.67	2.94
Net Debt / EBITDA Ratio	3.85	3.86	4.49	4.66	4.15	4.22
Net Debt / FCF Ratio	20.18	12.92	45.94	-5.58	17.11	9.59
Asset Turnover	0.37	0.37	0.35	0.34	0.34	0.34
Inventory Turnover	9.51	10.01	10.22	11.05	9.77	9.34
Quick Ratio	2.21	1.98	2.23	1.97	0.67	1.36
Current Ratio	2.82	2.46	2.75	2.42	0.81	2.15
Return on Equity (ROE)	19.18%	15.42%	10.46%	12.94%	-49.89%	22.14%
Return on Assets (ROA)	6.74%	6.04%	3.74%	4.29%	8.08%	6.17%
Return on Invested Capital (ROIC)	8.57%	7.64%	4.69%	6.02%	11.12%	7.46%
Return on Capital Employed (ROCE)	12.61%	12.28%	10.30%	10.59%	10.03%	9.78%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.36%	1.53%	1.17%	1.07%	-	1.74%
FCF Yield	1.94%	2.97%	1.16%	-	4.06%	2.69%
Buyback Yield / Dilution	-0.93%	-0.53%	-0.59%	-1.12%	-0.26%	-17.54%
Total Shareholder Return	-0.93%	-0.53%	-0.59%	-1.12%	-0.26%	-17.54%

SEC Filings: 10-K · 10-Q